Human Gene TherapyVol. 9, No. 10 NEWS AND COMMENTSFDA Report: Guidance for Industry: Guidance for Human Somatic Cell Therapy and Gene TherapyPublished Online:20 Mar 2008https://doi.org/10.1089/hum.1998.9.10-1513AboutSectionsPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail FiguresReferencesRelatedDetailsCited byAnalytical techniques currently used in the pharmaceutical industry for the quality control of RNA-based therapeutics and ongoing developmentsJournal of Chromatography A, Vol. 1651Contemporary Transposon Tools: A Review and Guide through Mechanisms and Applications of Sleeping Beauty, piggyBac and Tol2 for Genome Engineering11 May 2021 | International Journal of Molecular Sciences, Vol. 22, No. 10Regulation of Stem Cell-Based Research in India in Comparison with the US, EU and other Asian Countries: Current Issues and Future PerspectivesCurrent Stem Cell Research & Therapy, Vol. 15, No. 6Therapies targeting DNA and RNA in Huntington's diseaseThe Lancet Neurology, Vol. 16, No. 10The Effects of Harvesting Media on Biological Characteristics and Repair Potential of Neural Stem Cells after Traumatic Brain Injury23 September 2014 | PLoS ONE, Vol. 9, No. 9Brucella abortus Strain RB51 Leucine Auxotroph as an Environmentally Safe Vaccine for Plasmid Maintenance and Antigen OverexpressionApplied and Environmental Microbiology, Vol. 74, No. 22Production of research and clinical‐grade recombinant adeno‐associated virus vectorsEx vivo purging by adenoviral p53 gene therapy does not affect NOD-SCID repopulating activity of human CD34+ cells21 December 2001 | Cancer Gene Therapy, Vol. 8, No. 12Degenerated pIX-IVa2 adenoviral vector sequences lowers reacquisition of the E1 genes during virus amplification in 293 cells17 December 2001 | Gene Therapy, Vol. 8, No. 22Intratumoral Spread and Increased Efficacy of a p53-VP22 Fusion Protein Expressed by a Recombinant AdenovirusJournal of Virology, Vol. 75, No. 18Gene Therapy and Metabolic EngineeringMetabolic Engineering, Vol. 2, No. 2Gene Therapy: A New Challenge for Infection Control2 January 2015 | Infection Control & Hospital Epidemiology, Vol. 20, No. 08Compliance with Good Manufacturing Practices for facilities engaged in vector production, cell isolation, and genetic manipulationsCurrent Opinion in Biotechnology, Vol. 10, No. 3Adeno-associated virus-mediated gene deliveryThe Journal of Gene Medicine, Vol. 1, No. 3 Volume 9Issue 10Jul 1998 InformationCopyright 1998, Mary Ann Liebert, Inc.To cite this article:FDA Report: Guidance for Industry: Guidance for Human Somatic Cell Therapy and Gene Therapy.Human Gene Therapy.Jul 1998.1513-1524.http://doi.org/10.1089/hum.1998.9.10-1513Published in Volume: 9 Issue 10: March 20, 2008PDF download